DEM BioPharma is a Cambridge, Massachusetts biotechnology company developing first-in-class cancer therapeutics that target the signals solid tumors use to evade immune destruction. The company pioneers next-generation macrophage and innate-immune immunotherapies discovered through its proprietary CHoMP (Co-culture with Human Myeloid Phagocytes)… - View it on GitHub